Individual sulfonylureas and serious hypoglycemia in older people

Journal of the American Geriatrics Society

Volumn 44, Issue 7, 1996, Pages 751-755

  Shorr, Ronald I ^a,b,c   Ray, Wayne A ^a   Daugherty, James R ^a   Griffin, Marie R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Methodist Hospitals of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOHEXAMIDE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIPIZIDE; GLUCAGON; GLUCOSE; SUCROSE; SULFONYLUREA DERIVATIVE; TOLAZAMIDE; TOLBUTAMIDE;

AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DIABETES MELLITUS; DRUG USE; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL RECORD; MORTALITY; ORAL DRUG ADMINISTRATION; RETROSPECTIVE STUDY; RISK; STROKE;

EID: 0029949970     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb03729.x     Document Type: Article

References (33)

1. Seltzer HS. Drug-induced hypoglycemia: A review of 1418 cases. Endocrinol Metab Clin North Am 1989;18:163-183.
2. Malouf R, Brust JC. Hypoglycemia: Causes, neurological manifestations, and outcome. Ann Neurol 1985;17:421-430.
3. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med 1986;315:1245-1250.
4. Stepka M, Rogala H, Czyzyk A. Hypoglycemia: A major problem in the management of diabetes in the elderly. Aging (Milano) 1993;5:117-121.
5. Walter RM Jr. Hypoglycemia: Still a risk in the elderly. Geriatrics 1990;45:69-75.
6. Ruoff G. The management of non-insulin-dependent diabetes mellitus in the elderly. J Fam Pract 1993;36:329-335.
7. Kobayashi KA, Bauer A, Horn JR et al. Glipizide pharmacokinetics in young and elderly volunteers. Clin Pharm 1988;7:224-228.
8. Jackson JE, Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents: Part 1. Drugs. 1981;22:211-245.
9. Marker JC, Cryer PE, Clutter WE. Attenuated glucose recovery from hypoglycemia in the elderly. Diabetes 1992;41:671-678.
10. Meneilly GS, Cheung E, Tuokko H. Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 1994;43:403-410.
11. Ortiz FJ, Herman WH, Smith MJ, Halter JB. Diminished hypoglycemia counterregulation in older adults. Clin Res (Abstract)1992;40:195A.
12. Mori S, Ito H. Hypoglycemia in the elderly. Jpn J Med 1988;27:160-166.
13. Berger W, Caduff F, Pasquel M, Rump A. Die relative Häufigkeit der schweren sulfonylharnstoff-hypoglykämie in den letzten 25 Jahren in der Schweiz. Schweiz Med Wochenschr 1986;116:145-151.
14. Sugarman JR. Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insutin-dependent diabetes mellitus. Diabetes Res Clin Pract 1991;14:139-148.
15. U.S. Department of Health and Human Services. The International Classification of Diseases: ICD-9CM, 2nd Ed. Washington, DC: US Government Printing Office, 1980, p 910.
16. Beers MH, Ouslander JG, Fingold SF et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992;117:684-689.
17. Peters AL, Davidson MB. Use of sulfonylurea agents in older diabetic pa-tients. Clin Geriatr Med 1990;6:903-921.
18. Gerich JE. Oral hypoglyceamic agents. N Engl J Med 1989;321:1231-1245.
19. Williams G. Management of non-insulin-dependent diabetes mellitus. Lancet 1994;343:95-100.
20. Marchetti P, Giannarelli R, di Carlo A, Navalesi R. Pharmacokinetic optimi-sation of oral hypoglycaemic therapy. Clin Pharmacokinet 1991;21:308-317.
21. Payne CD. Generalized Linear Interactive Modelling Manual: The GLIM System. Release 3.77. Oxford: Royal Statistical Society, 1987.
22. Kales A, Bixler EO, Tan T et al. Chronic hypnotic-drug use: Ineffectiveness, drug-withdrawal insominia, and dependence. JAMA 1974;227:513-517.
23. Ferner RE, Neil HAW. Sulphonylureas and hypoglycaemia. Br Med J 1988;296:949-950.
24. Jennings AM, Wilson RM, Ward JD. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 1989;12:203-208.
25. Clarke BF, Campbell IW. Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics. Lancet 1975;1(7901):246-247.
26. Groop L, Groop PH, Stenman S et al. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. Diabetes Care 1987;10:71-78.
27. Chen H, Hamel FG, Siford G, Duckworth WC. Alteration of rat hepatic insulin metabolism by glyburide and glipizide. J Pharmacol Exp Ther 1993;264:1293-1298.
28. Groop L, Luzi L, Melander A et al. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Diabetes 1987;36:1320-1328.
29. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991;90:450-459.
30. Harrower AD, Wong C. Comparison of secondary failure rate between three second-generation Sulphonylureas. Diabetes Res 1990;13:19-21.
31. Harrower AD. Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different Sulphonylureas. Curr Med Res Opin 1985;9:676-680.
32. Harris MI. Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med 1990;6:703-719.
33. Kennedy DL, Piper JM, Baum C. Trends in the use of oral hypoglycemics: 1964-86. Diabetes Care 1988;11:558-562.